| 10406106 |
Sustained release formulations of nalbuphine |
Anand R. Baichwal, Philip A. Goliber, Thomas Sciascia, Donald Diehl, II, Brian Vogler +2 more |
2019-09-10 |
| 10172798 |
Sustained release formulation of nalbuphine |
Anand R. Baichwal, Philip A. Goliber, Thomas Sciascia, Donald Diehl, II, Brian Vogler +2 more |
2019-01-08 |
| 10166185 |
Excipient and oral solid dosage forms for oily drugs |
Michael Nagel |
2019-01-01 |
| 9351938 |
Sustained release formulation of nalbuphine |
Anand R. Baichwal, Philip A. Goliber, Thomas Sciascia, Donald Diehl, II, Brian Vogler +2 more |
2016-05-31 |
| RE45822 |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
Curtis Wright |
2015-12-22 |
| 9186330 |
Sustained release formulation of nalbuphine |
Anand R. Baichwal, Philip A. Goliber, Thomas Sciascia, Donald Diehl, II, Brian Vogler |
2015-11-17 |
| 8771732 |
Sustained release formulations of nalbuphine |
Anand R. Baichwal, Philip A. Goliber, Thomas Sciascia, Donald Diehl, II, Brian Vogler |
2014-07-08 |
| 8765175 |
Sustained release formulation of nalbuphine |
Anand R. Baichwal, Philip A. Goliber, Thomas Sciascia, Donald Diehl, II, Brian Vogler +2 more |
2014-07-01 |
| 8394812 |
Sustained release formulations of nalbuphine |
Anand R. Baichwal, Philip A. Goliber, Thomas Sciascia, Donald Diehl, II, Brian Vogler +2 more |
2013-03-12 |
| 7384653 |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
Curtis Wright |
2008-06-10 |
| 4996047 |
Sustained release drug-resin complexes |
William J. Kelleher |
1991-02-26 |